InfuSystem Holdings (INFU) Change in Accured Expenses (2010 - 2026)
InfuSystem Holdings' (INFU) quarterly Change in Accured Expenses came in at -$3.3 million in Q1 2026, down 111.03% YoY from $30.2 million in Q1 2025, and down 478.78% on a QoQ basis from -$575000.0 in Q4 2025.
InfuSystem Holdings (INFU) Change in Accured Expenses (2010 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has 11 years of Change in Accured Expenses data on file, last reported at -$3.3 million in Q1 2026.
- Quarterly Change in Accured Expenses fell 111.03% year-over-year to -$3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.5 million (down 114.39% YoY) and the FY2025 annual result came in at -$708000.0, down 4.73% from the prior year.
- Change in Accured Expenses retreated to -$3.3 million in Q1 2026, from -$575000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $2.7 million in Q4 2023 to a low of -$3.3 million in Q1 2026.
- A 5-year average of $37941.2 and a median of $313000.0 in 2023 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses surged 194.16% — and 2024, when it slumped 453.35%.
- Tracing INFU's Change in Accured Expenses over 5 years: stood at $1.7 million in 2022, then jumped by 55.22% to $2.7 million in 2023, then sank by 79.55% to $553000.0 in 2024, then slumped by 203.98% to -$575000.0 in 2025, then sank by 478.78% to -$3.3 million in 2026.
- The last three Change in Accured Expenses figures came in at -$3.3 million (Q1 2026), -$575000.0 (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 4.80 Mn |
| 10 | InfuSystem Holdings | 244.87 Mn | 243.90 Mn | 21.41 Mn | 725,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 725,000.00 |
| Jun 30, 2026 | 725,000.00 |
| Mar 31, 2026 | -3.33 Mn |
| Mar 31, 2026 | -3.33 Mn |
| Dec 31, 2025 | -575,000.00 |
| Dec 31, 2025 | -575,000.00 |
| Sep 30, 2025 | 1.84 Mn |
| Sep 30, 2025 | 1.84 Mn |
| Jun 30, 2025 | -398,000.00 |
| Jun 30, 2025 | -398,000.00 |
| Mar 31, 2025 | -1.58 Mn |
| Mar 31, 2025 | -1.58 Mn |
| Dec 31, 2024 | 553,000.00 |
| Dec 31, 2024 | 553,000.00 |
| Sep 30, 2024 | 2.04 Mn |
| Sep 30, 2024 | 2.04 Mn |
| Jun 30, 2024 | -2.16 Mn |
| Jun 30, 2024 | -2.16 Mn |
| Mar 31, 2024 | -1.11 Mn |
| Mar 31, 2024 | -1.11 Mn |